PHARMACOLOGY AND CLINICAL-APPLICATIONS OF CIS-PLATINUM

被引：10
作者：
JAVADPOUR, N [1 ]
机构：
[1] UNIV MARYLAND,SCH MED,DEPT SURG,DIV UROL,BALTIMORE,MD 21201
来源：
UROLOGY | 1985年 / 25卷 / 02期
关键词：
D O I：
10.1016/0090-4295(85)90533-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 160
页数：6
相关论文
共 44 条
[31]  
2-V
[32]  
SAMUELS ML, 1975, CANCER CHEMOTH REP 1, V59, P563
[33]   HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING IN PATIENTS RECEIVING CISPLATIN [J].
SCHILSKY, RL ;
ANDERSON, T .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (06) :929-931
[34]  
SCHMIDT J D, 1976, Urology, V7, P602, DOI 10.1016/0090-4295(76)90085-6
[35]   CHEMOTHERAPY PROGRAMS OF THE NATIONAL-PROSTATIC-CANCER-PROJECT (NPCP) [J].
SCHMIDT, JD ;
SCOTT, WW ;
GIBBONS, R ;
JOHNSON, DE ;
PROUT, GR ;
LOENING, S ;
SOLOWAY, M ;
DEKERNION, J ;
PONTES, JE ;
SLACK, NH ;
MURPHY, GP .
CANCER, 1980, 45 (07) :1937-1946
[36]  
THIGPEN T, 1978, P AM ASSOC CANC RES, V19, P332
[37]   VAB-6 COMBINATION CHEMOTHERAPY IN DISSEMINATED CANCER OF THE TESTIS [J].
VUGRIN, D ;
HERR, HW ;
WHITMORE, WF ;
SOGANI, PC ;
GOLBEY, RB .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (01) :59-61
[38]  
VUGRIN D, 1981, CANCER, V47, P833, DOI 10.1002/1097-0142(19810301)47:5<833::AID-CNCR2820470502>3.0.CO
[39]  
2-H
[40]  
WITTES R, 1979, CANCER TREAT REP, V63, P1533
12345